ClinicalTrials.Veeva

Menu

Study Evaluating SCA-136 Tolerability With Dose Titration and Food

Wyeth logo

Wyeth

Status and phase

Terminated
Phase 1

Conditions

Healthy

Treatments

Drug: SCA-136

Study type

Interventional

Funder types

Industry

Identifiers

NCT00420706
3153A1-105

Details and patient eligibility

About

To evaluate whether the tolerability of SCA-136 is improved by dosing with food or by increasing dose amounts in a step-wise fashion.

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy men or women, aged 18 to 50 years

Exclusion criteria

  • Abnormal vital signs, ECG, or lab results

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems